Vioxx Legal Defense: Merck Strategy May Offer Pointers To NSAID Marketers
This article was originally published in The Tan Sheet
Executive Summary
The legal liability from Merck's Vioxx recall could serve as a measuring stick for other marketers of anti-inflammatory drugs should their products face similar safety challenges
You may also be interested in...
Pfizer COX-2 Marketing, Safety Practices Questioned By DoJ
Pfizer is working to supply the Justice Department and several state attorneys general with materials related to the company's handling of marketing and safety issues associated with Celebrex and Bextra
Pfizer COX-2 Marketing, Safety Practices Questioned By DoJ
Pfizer is working to supply the Justice Department and several state attorneys general with materials related to the company's handling of marketing and safety issues associated with Celebrex and Bextra
Pfizer COX-2 Marketing, Safety Practices Questioned By DoJ
Pfizer is working to supply the Justice Department and several state attorneys general with materials related to the company's handling of marketing and safety issues associated with Celebrex and Bextra